Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Welcome to The Hill’s Technology newsletter {beacon} Technology Technology   The Big Story Stargate criticism tests Musk ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

President Trump's massive $500 billion AI infrastructure dubbed Stargate rustled plenty of feathers, reigniting a bitter feud ...

In the latest development in the pair’s longtime feud, Elon Musk, a key White House advisor as well as the founder of AI ...

OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...

OpenAI is putting its focus on AI infrastructure with Stargate at a time when rivals like China's DeepSeek are closing the ...

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Stargate, the project to build AI-focused data centers in the US, will reportedly get $19 billion from OpenAI and SoftBank.